Main trends of immune effects triggered by nanomedicines in preclinical studies
Blanka Halamoda-Kenzaoui, Susanne Bremer-Hoffmann Directorate F-Health, Consumers and Reference Materials, European Commission Joint Research Centre (JRC), Ispra (VA), Italy Abstract: The application of nanotechnology to emerging medicinal products is a crucial parameter for the implementation of...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b56e46c056e4b8399a74ddb452bae6a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|